Breckenridge Pharmaceutical, Inc. issued a nationwide recall on Monday for a specific lot of Propranolol Hydrochloride Extended-Release Capsules due to potential metal contamination.
The voluntary recall impacts 60 mg extended-release capsules distributed to wholesalers and pharmacies between October 26, 2026, and November 4, 2026. The firm said that the affected lot shared intermediate material with a separate, unreleased lot where metal contamination was initially identified.
While no illnesses or injuries have been officially linked to the medication as of today, the manufacturer warns that the presence of metal particles could cause damage to the oral cavity, esophagus, stomach, or intestinal lining.
- Stop usage immediately: If you possess a 60 mg bottle with lot number PK25110035 and an expiration date of May 2029, do not consume the remaining capsules.
- Verify your supply: Check the National Drug Code (NDC) 51991-817-01 on your packaging to confirm if your medication is part of the affected batch.
- Consult your physician: Contact your healthcare provider to discuss alternative therapies and ensure your blood pressure management remains uninterrupted.
Propranolol is a non-selective beta-blocker used to manage hypertension, heart disease, and various cardiac arrhythmias. By antagonizing beta-adrenergic receptors, the drug slows heart rate and reduces the force of contraction, which lowers the workload on the heart, as noted by the Cleveland Clinic.
| Identifier | Specification |
|---|---|
| Drug Name | Propranolol Hydrochloride ER |
| Lot Number | PK25110035 |
| NDC Number | 51991-817-01 |
| Expiration Date | May 2029 |
Breckenridge Pharmaceutical is conducting this recall with the knowledge of the U.S. Food and Drug Administration (FDA), although the agency has not yet released a formal public advisory. The medication was manufactured by Adare Pharma Solutions.
If you have been taking the medication from the identified lot, monitor for acute gastrointestinal distress. Please contact your pharmacy to arrange for a return of the unused product and to secure a safe, uncontaminated replacement. For specific inquiries, the manufacturer can be reached at 1-855-736-0807 or via email at [email protected].

- Cleveland Clinic. (2026). Propranolol Hydrochloride: Uses, Side Effects, and Mechanism of Action.
- Breckenridge Pharmaceutical, Inc. (2026). Voluntary Nationwide Recall Announcement for Propranolol Hydrochloride Extended-Release Capsules.